- Air pollution was associated with blood vessel damage among young, healthy adults.
- These findings suggest that healthcare providers should consider the cardiovascular effects of air pollution on all patients, not just those who are ill or elderly.
“These results substantially expand our understanding about how air pollution contributes to cardiovascular disease by showing that exposure is associated with a cascade of adverse effects,” said C. Arden Pope, Ph.D., study lead author and Mary Lou Fulton Professor of Economics at Brigham Young University in Provo, Utah.
Air pollution is known to contribute to cardiovascular disease and related deaths. In 2004, the American Heart Association released a scientific statement, updated in 2010, warning of the risk and recommending that people talk to their doctor about avoiding exposure to air pollution specific to their area. What remained unclear, however, was how air pollution actually affects the blood vessels to increase the risk of disease.
For this study, investigators analyzed the component of air pollution known as fine particulate matter (PM2.5) — the tiny pieces of solid or liquid pollution emitted from motor vehicles, factories, power plants, fires, and smoking. They found that periodic exposure to fine particulate matter was associated with several abnormal changes in the blood that are markers for cardiovascular disease. As air pollution rose, they found:
- small, micro-particles indicating cell injury and death significantly increased in number;
- levels of proteins that inhibit blood vessel growth increased; and
- proteins that signify blood-vessel inflammation also showed significant increases.
Study participants included 72 healthy, nonsmoking, adults in Provo, Utah. Their average age was 23, most were white, and more than half were male. During the winters of 2013, 2014, and 2015, participants provided blood samples, which researchers then tested for markers of cardiovascular disease. Due to the unique weather and geographical features of Provo, they were able to evaluate these informative blood markers with various levels of air pollution.
However, researchers noted that the third study year, 2015, was relatively unpolluted, which could have affected the results.
Other co-authors are James P. McCracken, Ph.D.; Wesley Abplanalp, Ph.D.; Daniel J. Conklin, Ph.D.; and Timothy O’Toole, Ph.D. Author disclosures are on the manuscript.
The National Institutes of Health funded the study.